Strategic Sanitization: Michael Jackson Biopic Reaches Theaters Amidst Reshoots and Script Controversy

The Michael Jackson biopic "Michael" faces scrutiny over its sanitized narrative and costly reshoots as it prepares for a massive global theatrical debut.

By: AXL Media

Published: Apr 18, 2026, 8:40 AM EDT

Source: BBC Culture

The Production and Strategic Pivot

Produced by Graham King—the architect behind the $900 million success of Bohemian Rhapsody—the biopic Michael has navigated a minefield of legal and narrative challenges. While early drafts of the screenplay by John Logan (Gladiator) were intended to explore the 1990s child abuse allegations, the finished film has undergone a dramatic structural change. Industry reports indicate that the third act, once dedicated to the Jordan Chandler scandal, has been largely excised.

The shift necessitated 22 days of additional shooting in June 2025, costing an estimated $10 million to $15 million. These costs were reportedly covered by the Jackson estate, which maintains a producer role in the project. The film now culminates with the 1988 Bad tour, effectively framing the narrative as a celebration of Jackson’s "King of Pop" era while deferring more contentious subject matter to potential sequels.

Regulatory and Creative Scrutiny

The creative direction of the film has sparked intense debate among historians and documentarians. Dan Reed, director of the Emmy-winning Leaving Neverland, has criticized the project, alleging that earlier versions of the script contained "outright lies" regarding Jackson’s relationships with accusers. Lawyers for the Jackson estate have countered these claims, dismissing Reed’s assertions as "defamatory speculative assertions" since he had not viewed the final theatrical cut.

A significant legal hurdle also influenced the final edit. Due to the terms of the 1994 out-of-court settlement with Jordan Chandler, the accuser cannot be portrayed or referenced in any commercial film. This "read-only" legal constraint essentially forced the production to pivot away from the 1994 scandal, leading Lionsgate to market the film as "Part One" of a broader biographical series.